Clinical Trial

ioMRI in the Surgery of Brain Metastases.

Study acronym: MET-MRI
Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to improve the surgical treatment of brain metastases through the use of advanced imaging techniques. The investigators are examining how intraoperative MRI (iMRI) can aid surgeons in precisely locating and removing tumors, with the potential to enhance surgical outcomes and reduce the need for additional procedures. While iMRI offers the promise of better tumor visualization during surgery, it is also associated with longer surgical times and may carry the risk of increased complications. This study seeks to carefully evaluate these aspects to determine the overall benefits and challenges of iMRI in brain metastasis surgeries. The ultimate aim is to enhance treatment effectiveness and improve recovery and health outcomes for participants dealing with brain metastases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-22.
Trial Details
NCT Number NCT07197632
Lead Sponsor Technical University of Munich
Conditions Brain Metastases
Enrollment 154 participants
Start Date 2025-01-17
Primary Completion 2027-01-01 (estimated)
Study Completion 2030-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-05